20 Hrs
Source:
الخليج
Britain approves Orphogryberon for weight loss
Despite being classified as a weight loss and diabetes treatment, the drug "Orforglibron" from Eli Lilly has recently been approved in Britain. This marks the first such authorization in Europe after a thorough evaluation of its safety, quality, and efficacy. However, it will not immediately be available through the NHS, and it may take some time to obtain. The medication aims to treat obesity and type 2 diabetes using the "GLP-1" class.
Size: 120%Text Size
Notice: This Is an AI-Generated Summary
Comments (0)